ASO Visual Abstract: Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-transit Melanoma Metastases
Ann Surg Oncol
.
2022 Oct;29(11):7031-7032.
doi: 10.1245/s10434-022-12266-w.
Epub 2022 Aug 22.
Authors
Anna K Lawless
#
1
2
3
,
David J Coker
#
1
2
3
,
Serigne N Lo
1
2
,
Tasnia Ahmed
1
,
Richard A Scolyer
1
2
4
5
,
Sydney Ch'ng
1
2
3
6
,
Omgo E Nieweg
1
2
3
,
Kerwin Shannon
1
3
,
Andrew Spillane
1
2
7
,
Jonathan R Stretch
1
2
3
,
John F Thompson
#
1
2
3
,
Robyn P M Saw
#
8
9
10
Affiliations
1
Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
2
Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
3
Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
4
Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia.
5
Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.
6
RPA Institute of Academic Surgery, Sydney Local Health District, NSW, Australia.
7
Department of Breast and Melanoma Surgery, Royal North Shore Hospital, Sydney, NSW, Australia.
8
Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. robyn.saw@melanoma.org.au.
9
Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. robyn.saw@melanoma.org.au.
10
Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. robyn.saw@melanoma.org.au.
#
Contributed equally.
PMID:
35994160
DOI:
10.1245/s10434-022-12266-w
No abstract available
MeSH terms
Humans
Melanoma* / pathology
Neoplasm Recurrence, Local / pathology
Neoplasm Recurrence, Local / surgery
Skin Neoplasms* / pathology